| scholarly article | Q13442814 |
| P2093 | author name string | Jean-Jacques Risso | |
| Laurent Chazalviel | |||
| Hélène N David | |||
| Jacques H Abraini | |||
| Benoît Haelewyn | |||
| Myriam Lecocq | |||
| Mickael Degoulet | |||
| P2860 | cites work | The neuroprotective effect of xenon administration during transient middle cerebral artery occlusion in mice | Q48950152 |
| Ischemia and Stroke | Q56969358 | ||
| The effect of helium-oxygen mixtures on body temperature | Q68803802 | ||
| Helium-induced preconditioning in young and old rat heart: impact of mitochondrial Ca(2+) -sensitive potassium channel activation | Q79690485 | ||
| Noble gases without anesthetic properties protect myocardium against infarction by activating prosurvival signaling kinases and inhibiting mitochondrial permeability transition in vivo | Q80838418 | ||
| Psychophysiological reactions in humans during an open sea dive to 500 m with a hydrogen-helium-oxygen mixture | Q28243635 | ||
| Pathological changes induced in cerebrocortical neurons by phencyclidine and related drugs | Q28270170 | ||
| NMDA Antagonist Neurotoxicity: Mechanism and Prevention | Q28273543 | ||
| Heliox and oxygen reduce infarct volume in a rat model of focal ischemia | Q33283142 | ||
| Effect of nitrous oxide on neuronal damage and extracellular glutamate concentration as a function of mild, moderate, or severe ischemia in halothane-anesthetized gerbils | Q33337104 | ||
| Effects of the administration of a-methyl-p-tyrosine on the striatal dopamine increase and the behavioral motor disturbances in rats exposed to high pressure | Q33435701 | ||
| Selfotel in acute ischemic stroke : possible neurotoxic effects of an NMDA antagonist | Q33888681 | ||
| Effects of gaseous anesthetics nitrous oxide and xenon on ligand-gated ion channels. Comparison with isoflurane and ethanol | Q33920428 | ||
| Determination of anesthetic requirement in rats | Q34219061 | ||
| Two-pore-domain K+ channels are a novel target for the anesthetic gases xenon, nitrous oxide, and cyclopropane | Q34292344 | ||
| Potentially neuroprotective and therapeutic properties of nitrous oxide and xenon | Q34453234 | ||
| Nitrous oxide (laughing gas) is an NMDA antagonist, neuroprotectant and neurotoxin | Q34464493 | ||
| Xenon provides short-term neuroprotection in neonatal rats when administered after hypoxia-ischemia | Q34479120 | ||
| Glutamate in CNS disorders as a target for drug development: an update | Q35992523 | ||
| Neuroprotection for ischemic stroke using hypothermia | Q36455056 | ||
| The uses of helium and xenon in current clinical practice | Q37090460 | ||
| Clinical concise review: Mechanical ventilation of patients with chronic obstructive pulmonary disease | Q37147087 | ||
| Focal cerebral ischemia in the rat: topography of hemodynamic and histopathological changes | Q39352397 | ||
| Protein crystallography under xenon and nitrous oxide pressure: comparison with in vivo pharmacology studies and implications for the mechanism of inhaled anesthetic action. | Q41048067 | ||
| Xenon attenuates cardiopulmonary bypass-induced neurologic and neurocognitive dysfunction in the rat. | Q44329352 | ||
| Reduction of ischemic brain damage by nitrous oxide and xenon. | Q44606739 | ||
| Intraischemic nitrous oxide alters neither neurologic nor histologic outcome: a comparison with dizocilpine | Q45034041 | ||
| Different degrees of hypothermia after experimental stroke: short- and long-term outcome | Q45112055 | ||
| Neuroprotection by nitrous oxide: facts and evidence | Q46446570 | ||
| Xenon preconditioning reduces brain damage from neonatal asphyxia in rats | Q46611068 | ||
| Postischemic nitrous oxide alone versus intraischemic nitrous oxide in the presence of isoflurane: what it may change for neuroprotection against cerebral stroke in the rat. | Q46613051 | ||
| Xenon and hypothermia combine to provide neuroprotection from neonatal asphyxia. | Q46623106 | ||
| Xenon/hypothermia neuroprotection regimes in spontaneously breathing neonatal rats after hypoxic-ischemic insult: the respiratory and sedative effects | Q46739925 | ||
| The neuroprotective effects of xenon and helium in an in vitro model of traumatic brain injury | Q46793709 | ||
| Neuroprotective effects of xenon: a therapeutic window of opportunity in rats subjected to transient cerebral ischemia | Q46892046 | ||
| Asynchronous administration of xenon and hypothermia significantly reduces brain infarction in the neonatal rat. | Q48315934 | ||
| How does xenon produce anaesthesia? | Q48332940 | ||
| Neuroprotection of the brain during cardiopulmonary bypass: a randomized trial of remacemide during coronary artery bypass in 171 patients | Q48357237 | ||
| Effect of nitrous oxide on neurologic and neuropsychological function after intracranial aneurysm surgery | Q48506666 | ||
| Xenon and hypothermia combine additively, offering long-term functional and histopathologic neuroprotection after neonatal hypoxia/ischemia | Q48513991 | ||
| P433 | issue | 6 | |
| P304 | page(s) | 1159-1165 | |
| P577 | publication date | 2009-04-22 | |
| P1433 | published in | Journal of Cerebral Blood Flow & Metabolism | Q14663525 |
| P1476 | title | Post-ischemic helium provides neuroprotection in rats subjected to middle cerebral artery occlusion-induced ischemia by producing hypothermia | |
| P478 | volume | 29 |
| Q43733724 | A method for calculating the gas volume proportions and inhalation temperature of inert gas mixtures allowing reaching normothermic or hypothermic target body temperature in the awake rat. |
| Q36765480 | A randomized trial of the effects of the noble gases helium and argon on neuroprotection in a rodent cardiac arrest model. |
| Q47797677 | A technique for administering xenon gas anesthesia during surgical procedures in mice. |
| Q39458475 | Advances in molecular mechanism of cardioprotection induced by helium |
| Q33713070 | Anaesthetic-related neuroprotection: intravenous or inhalational agents? |
| Q35595815 | Application of medical gases in the field of neurobiology |
| Q33873386 | Argon neuroprotection. |
| Q34153156 | Bench-to-bedside review: Molecular pharmacology and clinical use of inert gases in anesthesia and neuroprotection |
| Q33844760 | Drug-induced hypothermia in stroke models: does it always protect? |
| Q35163104 | Effect of isobaric breathing gas shifts from air to heliox mixtures on resolution of air bubbles in lipid and aqueous tissues of recompressed rats |
| Q39703504 | Effect of noble gases on oxygen and glucose deprived injury in human tubular kidney cells. |
| Q47437607 | Effects of combined helium pre/post-conditioning on the brain and heart in a rat resuscitation model. |
| Q28481156 | Ex vivo and in vivo neuroprotection induced by argon when given after an excitotoxic or ischemic insult |
| Q92136783 | Gaseous mediators: an updated review on the effects of helium beyond blowing up balloons |
| Q47706328 | Internal and external cooling methods and their effect on body temperature, thermal perception and dexterity |
| Q35321053 | Moderately delayed post-insult treatment with normobaric hyperoxia reduces excitotoxin-induced neuronal degeneration but increases ischemia-induced brain damage |
| Q39282003 | Neuroprotective mechanisms and translational potential of therapeutic hypothermia in the treatment of ischemic stroke. |
| Q93019347 | Noble gas neuroprotection: xenon and argon protect against hypoxic-ischaemic injury in rat hippocampus in vitro via distinct mechanisms |
| Q38851190 | Pharmacological hypothermia: a potential for future stroke therapy? |
| Q37116436 | The role of helium gas in medicine |
| Q36316301 | Time-dependent effects of hypothermia on microglial activation and migration |
| Q90616682 | Ultrasound Responsive Noble Gas Microbubbles for Applications in Image-Guided Gas Delivery |
| Q46928898 | Xenon-helium gas mixture at equimolar concentration of 37.5% protects against oxygen and glucose deprivation-induced injury and inhibits tissue plasminogen activator |
| Q86050974 | [Neuroprotection by noble gases: New developments and insights] |
Search more.